Lexeo Therapeutics (NASDAQ:LXEO) CEO Sells $10,741.70 in Stock
MarketBeat
Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Get Free Report) CEO Richard Townsend sold 3,295 shares of Lexeo Therapeutics stock in a transaction dated Tuesday, November 17th. The stock was sold at an average price of $3.26, for a total value of $10,741.70. Following the sale, the chief executive officer directly owned 373,483 shares in the company, valued at approximately $1,217,554.58. This trade represents a 0.87% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
NASDAQ:LXEO